Human Phenotype Ontology

About
MSeqDR-LSDB
Tools
- mtDNA Tool:
- mvTool
- Phy-Mer
- MToolBox
- mvTool for Haplogroup
- mvTool with HmtDB
- MitoMaster
- MitoTIP tRNA Scoring
- MSeq-OpenCGA
- Variant Tool:
- VariantOneStop
- Quick-Mitome
- Quick-Mitome-Report
- HBCR Exome (Retired)
- POLG Patho. Server
- Data - Awsomics GeEx
- Expert Panel
- Panel Tool:
- Gene Panel Examiner
- Transgenomic_NuclearMitome
- Pedigree Maker
- json2table
Phenome
- Disease Portal
- HPO Ontology Browser
- Core Symptoms (draft)
- NAMDC-HPO Mapping (retired)
- Expert Panel
- Clinical
- Overview
- Leigh Syndrome Resource
Collaboration
Submission

Hello! Guest! Please Login or Register! Clinician Mode

Examples Gene: MT-ND1, POLG, Region: M:1-1000 Variant: m.8993T>G, 1:g.10042757T>C rs3888511 MSCV_0000006, ClinVar: RCV000000015, Disease: Leigh syndrome, Phenotype: Retinopathy

Grandparent Node:
Abnormality of the pancreas (HP:0001732)

Grandparent Node:
Neoplasm by anatomical site (HP:0011793)

Parent Node:
Neoplasm of the pancreas (HP:0002894)

..Starting node
..Pancreatic adenocarcinoma (HP:0006725)

Term ID:

6725

Name:

Pancreatic adenocarcinoma

Synonym:

Definition:

The presence of an adenocarcinoma of the pancreas.

Comments:

Reference:

HP:0006725

Genes and Diseases:

Child Nodes:

Sister Nodes:

Pancreatic islet cell adenoma (HP:0008261)

Pancreatic squamous cell carcinoma (HP:0012142)

Pancreatoblastoma (HP:0100757)

Input	HPO ID	HPO term	Distance	Gene	Gene id entrez	DiseaseId	DiseaseName	DiseaseMIM	ConceptID	Source	Typical association	ClinVar variants	HGNC ID	GeneMIM
HPO disease - gene - phenotype typical associations:
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	BRCA1 CL E G H	672	1333	Chromosome 19, ring		CN036553	ORPHA	1	12586	1100	113705
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	BRCA1 CL E G H	672	1333	Chromosome 19, ring		CN036553	ORPHA	1	12207	1100	113705
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	BRCA2 CL E G H	675	1333	Chromosome 19, ring		CN036553	ORPHA	1	14742	1101	600185
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	BRCA2 CL E G H	675	1333	Chromosome 19, ring		CN036553	ORPHA	1	13912	1101	600185
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	CDC73 CL E G H	79577	145001	Hyperparathyroidism 2	145001	C1704981	OMIM	1	828	16783	607393
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	CDC73 CL E G H	79577	145001	Hyperparathyroidism 2	145001	C1704981	OMIM	1	704	16783	607393
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	CDKN2A CL E G H	1029	1333	Chromosome 19, ring		CN036553	ORPHA	1	1062	1787	600160
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	CDKN2A CL E G H	1029	1333	Chromosome 19, ring		CN036553	ORPHA	1	971	1787	600160
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	CDKN2A CL E G H	1029	606719	Melanoma-pancreatic cancer syndrome	606719	C1838547	OMIM	1	1062	1787	600160
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	CDKN2A CL E G H	1029	606719	Melanoma-pancreatic cancer syndrome	606719	C1838547	OMIM	1	971	1787	600160
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	KRAS CL E G H	3845	1333	Chromosome 19, ring		CN036553	ORPHA	1	341	6407	190070
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	KRAS CL E G H	3845	1333	Chromosome 19, ring		CN036553	ORPHA	1	331	6407	190070
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	PALB2 CL E G H	79728	1333	Chromosome 19, ring		CN036553	ORPHA	1	4245	26144	610355
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	PALB2 CL E G H	79728	1333	Chromosome 19, ring		CN036553	ORPHA	1	3925	26144	610355
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	PALLD CL E G H	23022	1333	Chromosome 19, ring		CN036553	ORPHA	1	614	17068	608092
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	PALLD CL E G H	23022	1333	Chromosome 19, ring		CN036553	ORPHA	1	546	17068	608092
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	SMAD4 CL E G H	4089	1333	Chromosome 19, ring		CN036553	ORPHA	1	1495	6770	600993
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	SMAD4 CL E G H	4089	1333	Chromosome 19, ring		CN036553	ORPHA	1	1359	6770	600993
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	TP53 CL E G H	7157	1333	Chromosome 19, ring		CN036553	ORPHA	1	2464	11998	191170
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	TP53 CL E G H	7157	1333	Chromosome 19, ring		CN036553	ORPHA	1	2280	11998	191170
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	CDC73 CL E G H	79577	99880				ORPHA	0	828	16783	607393
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	CDC73 CL E G H	79577	99880				ORPHA	0	704	16783	607393
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	CDC73 CL E G H	79577	143				ORPHA	0	828	16783	607393
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	CDC73 CL E G H	79577	143				ORPHA	0	704	16783	607393
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	EPCAM CL E G H	4072	144				ORPHA	0	374	11529	185535
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	EPCAM CL E G H	4072	144				ORPHA	0	360	11529	185535
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	FAN1 CL E G H	22909	144				ORPHA	0	361	29170	613534
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	FAN1 CL E G H	22909	144				ORPHA	0	351	29170	613534
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	KRAS CL E G H	3845	144				ORPHA	0	341	6407	190070
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	KRAS CL E G H	3845	144				ORPHA	0	331	6407	190070
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	MLH1 CL E G H	4292	144				ORPHA	0	3763	7127	120436
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	MLH1 CL E G H	4292	144				ORPHA	0	3540	7127	120436
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	MLH3 CL E G H	27030	144				ORPHA	0	763	7128	604395
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	MLH3 CL E G H	27030	144				ORPHA	0	634	7128	604395
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	MSH2 CL E G H	4436	144				ORPHA	0	4964	7325	609309
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	MSH2 CL E G H	4436	144				ORPHA	0	4607	7325	609309
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	MSH6 CL E G H	2956	144				ORPHA	0	6219	7329	600678
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	MSH6 CL E G H	2956	144				ORPHA	0	5717	7329	600678
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	NTHL1 CL E G H	4913	454840				ORPHA	0	902	8028	602656
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	NTHL1 CL E G H	4913	454840				ORPHA	0	755	8028	602656
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	PIK3CA CL E G H	5290	144				ORPHA	0	613	8975	171834
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	PIK3CA CL E G H	5290	144				ORPHA	0	544	8975	171834
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	PMS1 CL E G H	5378	144				ORPHA	0	92	9121	600258
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	PMS1 CL E G H	5378	144				ORPHA	0	85	9121	600258
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	PMS2 CL E G H	5395	144				ORPHA	0	3421	9122	600259
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	PMS2 CL E G H	5395	144				ORPHA	0	3154	9122	600259
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	RNF43 CL E G H	54894	157798				ORPHA	0	322	18505	612482
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	RNF43 CL E G H	54894	157798				ORPHA	0	221	18505	612482
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	STK11 CL E G H	6794	2869	Hypertrophic osteoarthropathy, primary or idiopathic			ORPHA	0	1945	11389	602216
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	STK11 CL E G H	6794	2869	Hypertrophic osteoarthropathy, primary or idiopathic			ORPHA	0	1820	11389	602216
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	TGFBR2 CL E G H	7048	144				ORPHA	0	750	11773	190182
HP:0006725	HP:0006725	Pancreatic adenocarcinoma	0	TGFBR2 CL E G H	7048	144				ORPHA	0	694	11773	190182

Genes (22) :BRCA1 BRCA2 CDC73 CDKN2A EPCAM FAN1 KRAS MLH1 MLH3 MSH2 MSH6 NTHL1 PALB2 PALLD PIK3CA PMS1 PMS2 RNF43 SMAD4 STK11 TGFBR2 TP53

Diseases (9) :1333 99880 143 145001 606719 144 454840 157798 2869

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is August 2021 release.

Feedback about the webpages , or email to MSeqDR webmaster: Lishuang Shen